Unlock this StockReport nowClick to Unlock

1nkemia IUCT SA

IKM €0.402 -0.0  -4.7%
11:00am

Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value
Margin of Safety (beta)
Screens Passed 2
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 2018E 2019E CAGR / Avg
Revenue €m
Operating Profit €m
Net Profit €m
EPS Reported
EPS Normalised
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc €m
Working Capital €m
Net Fixed Assets €m
Net Debt €m
Book Value €m
Average Shares m
Book Value ps +6.1%

FINANCIAL BRIEF: For the fiscal year ended 31 December 2017, 1nkemia IUCT Group SA revenues increased from EUR2M to EUR4.7M. Net loss increased from EUR99K to EUR721K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Other Non Rec. I/E - Non Business Activ. decrease of 55% to EUR933K (income), Labor - Salaries increase of 22% to EUR2.5M (expense). more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score  
E+
E+
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
vs.
market
vs.
industry
Recent History
Latest interim period (ended 31st Dec '17) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2018
31st Dec 2019

Price Target: N/A
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a () () () () () ()
Consensus Estimate
1m Change
3m Change
Broker Consensus Trend
Broker Recommendations for 1nkemia IUCT SA
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts:

Named Brokers and Analysts
There are no named brokers.

Profile Summary

Inkemia IUCT Group SA is a Spain-based company primarily specialized in the biotechnological sector. The Company provides products and services for chemical, pharmaceutical, biopharmaceutical, life science and related industry. The Company’s activity is related to the generation, promotion, development and sale of products and services. The Company transforms its knowledge and know-how into a pipeline of products, processes, services and technological platforms. Its solutions are specialized, integrated and protected by patents. The main areas of expertise are related to drugs development, industrial biotechnology and green chemistry. The Company has a number of subsidiaries, including IUCT SA and IUCT Empren SL.

No Management Information.

No. of Employees: 45 No. of Shareholders: n/a


Last Annual December 31st, 2017
Last Interim December 31st, 2017
Public Since December 21, 2012
Shares in Issue 26,897,453
Free Float 11.9m (44.1%)
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Madrid Stock Exchange
Eligible for an ISA? a SIPP?

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2018.


Should you buy IKM

Access IKM Analytics Now!

FREE TRIAL or TAKE THE TOUR
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis